| APC | Adenomatous polyposis coli (gene) |
| CC | Cholangiocarcinoma |
| CRC | Colorectal cancer |
| EAR | Excess absolute risk |
| EPCAM | Epithelial cell adhesion molecule (gene) |
| ESCC | Esophageal squamous cell carcinoma |
| FAP | Familial adenomatous polyposis |
| GI | Gastrointestinal |
| HCC | Hepatocellular carcinoma |
| HNSCC | Head and neck squamous cell carcinoma |
| HPV | Human papillomavirus |
| IACR | International Association of Cancer Registries |
| IARC | International Agency for Research on Cancer |
| IMRT | Intensity-modulated radiotherapy |
| MLH1, MSH2, MSH6, PMS2 | DNA mismatch repair genes |
| MSI | Microsatellite instability |
| O/E | Observed-to-expected ratio |
| PDAC | Pancreatic ductal adenocarcinoma |
| SABR | Stereotactic ablative radiotherapy |
| SEER | Surveillance, Epidemiology, and End Results |
| SIR | Standardized incidence ratio |
| SPM | Second primary malignancy |
| VMAT | Volumetric modulated arc therapy |